Immutep S.A

immutep.com

Immutep S.A

Parc Club Orsay, 2, rue Jean Rostand,
91893 Orsay
France
immutep.com
Contact
Profile Products News

About Immutep S.A

Immutep S.A. is a biopharmaceutical company developing immunostimulatory factors for the treatment of cancer and chronic infectious diseases and immunomodulatory therapeutic antibodies for the treatment of cancer or autoimmune disease.

Read more about Immutep S.A

Advertisement

Revolutionize your production: real-time Raman analysis for maximum efficiency
Revolutionize your production: real-time Raman analysis for maximum efficiency
Efficient inline analysis for liquids and solids
Efficient inline analysis for liquids and solids
User-friendly software for effortless Design of Experiments (DoE)
User-friendly software for effortless Design of Experiments (DoE)

Product portfolio of Immutep S.A

Product portfolio

Show all

News about Immutep S.A

Immutep S.A

13-Apr-2012 | business & finance

Immutep and Lonza sign agreement for cell line selection, cell banking and process development of ImmuFact(R) IMP321

Immutep and Lonza announced an agreement for cell line selection, master cell banking and process development of ImmuFact(R) IMP321. Lonza will initiate ...

Read news
Immutep S.A

11-Jan-2011 | research and development

Immutep and GlaxoSmithKline sign licence agreement for IMP731, a therapeutic antibody for the treatment of autoimmune diseases

Immutep S.A. announced the execution of a licence agreement granting GSK exclusive worldwide rights to ImmuTune(R) IMP731 and any other antibodies that ...

Read news
Show more news about Immutep S.A

Here you will find Immutep S.A

Last viewed contents

INFORM GmbH - Aachen, Germany

INFORM GmbH - Aachen, Germany

Go to page